期刊文献+

化疗栓塞子宫动脉在宫颈癌术前的应用

Preoperative Interventional Chemoembolization for Treatment of Cervical Cancer
原文传递
导出
摘要 目的探讨子宫动脉化疗栓塞在宫颈癌根治术前的临床疗效。方法对2003年2月—2008年11月期间共98例宫颈癌根治术前1个月对子宫动脉进行化疗栓塞。介入术中用化疗药为顺铂,介入术后3d内用化疗药博莱霉素与异环磷酰胺,栓塞剂为超液态碘化油及高压消毒过的明胶海绵颗粒。结果 98例宫颈癌患者经过术前经动脉插管化疗栓塞后顺利经外科手术切除,术后标本病理切片可见大量坏死组织。结论宫颈癌根治术前介入性化疗栓塞可有效缩小肿瘤体积,增加外科手术成功率。 Objective To assess the effectiveness of preoperative interventional chemoembolization in the treatment of cervical cancer and to observe the pathological changes of the tumor after the procedure. Methods During the period of Feb. 2003 - Nov. 2008. preoperative interventional chemoembolization was performed in 98 patients with cervical cancer. The antineoplastic drugs included cisplatin, bleomycin and ifosfamide. In all patients,interventional arterial infusin chemotherapy was carried out befor the embolization of bilateral tumor - feeding arteries with gelfoam was made. Results Totally 98 patients underwent radical resection surgery after 1 time of chemoembolization. Pathologically, massive necrosis and of cervical cancer ymphocytic infiltration were found within the tumor. Conclusion For the treatment the preoperative interventional chemoembolization can effectively decrease the tumor size and reduce blood loss during operation, moreover, even HCR can be obtained in some patients
出处 《医药论坛杂志》 2010年第19期46-47,共2页 Journal of Medical Forum
关键词 宫颈癌 介入治疗 化疗栓塞 Carcinoma of uterine cervix Intervention Chemoembolization
  • 相关文献

参考文献1

二级参考文献26

  • 1程晓东,谢幸,吕卫国.局部晚期宫颈癌新辅助化疗临床应用的进展[J].中华医学杂志,2005,85(30):2154-2156. 被引量:31
  • 2Chao A, Wang TH, Lee YS, et al. Molecular characterization of adenocarcinoma and squamous carcinoma of the uterine cervix using microarray analysis of gene expression [J]. Int J Cancer, 2006, 119:91 -98.
  • 3Wong YH, Sahota DS, Cheung TH. et al. Expression pattern associated with radiotherapy sensitivity in cervical cancer [J]. Cancer, 2006, 3:189 - 195.
  • 4Fregnani JH, Latorre MR, Novik PR, et al. Assessment of pelvic lymph node micrometastatic disease in stages IB and IIA of carcinoma of the uterine cervix[J]. Int Jec Gynol Cancer, 2006, 16:1188 - 1194.
  • 5Baalbergen A,Ewing-Graham PC, Hop WC, et al. Prognosticfactors in adenocarcinoma of the uterine cervix [J]. Gynecol Oncol, 2004, 92:262 - 267.
  • 6Noriyuki M, Sumi T, Zhi X, et al. Vascular endothelial growth factor, matrix metalloproteinases, and cyclooxygenase-2 influence prognosis of uterine cervical cancer in young women[J]. Int J Oncol, 2007, 31:531 -536.
  • 7Lona M. Tomicie 1, Dotlic S, etal. Denocarcinoma of uterine cervix-prngnostic significance of clinicopathologic parameters[J]. Croat Med J, 2005, 46:397 - 403.
  • 8Chargui R, Damak T, Khornsi B, et al. prognostic factors and clinicopathologic characteristics of invasive adencarcinoma of the uterine cervix [J]. Am J Obstet. Gynecol, 2006, 194:43 - 48.
  • 9Nagai N, Hirata E, Kusuda T, et al. Villoglandular papillary adenoeareinoma of the uterine cervix responding to neoadjuvanlchemotherapy with docetaxel and cisplatin: report[J]. Int J Gvnecol Cancer, 2005, 15: 1187- 1190.
  • 10Leung TW, Xue WC, Cheung AN, et al. Proliferation to apoptosis ratio as a prognostic marker in adenocarcinoma of uterine cervix [J], Gynecol Oncol, 2004, 92: 866- 872.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部